Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Inotiv, Inc. Director's Dealing 2013

Jan 17, 2013

34595_dirs_2013-01-17_8ea44b48-60b1-4661-afa9-d7fa4b6ea94b.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOANALYTICAL SYSTEMS INC (BASI)
CIK: 0000720154
Period of Report: 2013-01-16

Reporting Person: Devine John P (VP--Toxicology)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2013-01-16 Option to Purchase Common Shares $1.4 A 500 Acquired 2023-01-16 Common Shares (500) Direct

Footnotes

F1: The options vest and become exercisable in two equal annual installments on each of the first two anniversaries of the date of grant.